We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
-15.19%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$2.21B
AUM Growth
-$530M
(-19%)
Cap. Flow
-$60M
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
511
New
25
Increased
176
Reduced
220
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progyny
PGNY
|
+$11M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$8.87M |
| 3 |
RTX Corp
RTX
|
+$8.14M |
| 4 |
Akamai
AKAM
|
+$5.56M |
| 5 |
AYX
Alteryx Inc
AYX
|
+$4.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSCM
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
|
+$11.2M |
| 2 |
Ubiquiti
UI
|
+$10.8M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$7.24M |
| 4 |
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
|
+$5.94M |
| 5 |
QuantumScape Corp
QS
|
+$5.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.48% |
| 2 | Financials | 13.91% |
| 3 | Industrials | 11.76% |
| 4 | Healthcare | 11.27% |
| 5 | Consumer Discretionary | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $439K | 0.02% |
12,616
-983
| -7% | -$35.5K |
|
|
RFMZ
352
RiverNorth Flexible Municipal Income Fund II
RFMZ
$328M
| $436K | 0.02% |
30,000
| – | – |
|
353
Humana
HUM
$46.1B
| $434K | 0.02% |
927
+9
| +1% | +$4K |
|
354
Cedar Fair
FUN
$1.74B
| $433K | 0.02% |
9,866
+200
| +2% | +$9.7K |
|
355
Boeing
BA
$181B
| $425K | 0.02% |
3,112
-1,173
| -27% | -$173K |
|
356
iShares S&P 500 Value ETF
IVE
$50.1B
| $419K | 0.02% |
3,047
+212
| +7% | +$31.3K |
|
357
ARK Blockchain & Fintech Innovation ETF
ARKF
$767M
| $416K | 0.02% |
26,870
-13,005
| -33% | -$263K |
|
358
Travelers Companies
TRV
$77.2B
| $414K | 0.02% |
+2,449
| New | +$426K |
|
359
Fortune Brands Innovations
FBIN
$5.84B
| $413K | 0.02% |
8,060
-376
| -4% | -$22K |
|
360
Gilead Sciences
GILD
$170B
| $410K | 0.02% |
6,634
+609
| +10% | +$37.7K |
|
361
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $406K | 0.02% |
53,035
+1,685
| +3% | +$13.4K |
|
362
ASML
ASML
$714B
| $400K | 0.02% |
841
+69
| +9% | +$38.5K |
|
|
MMP
363
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $400K | 0.02% |
8,373
+60
| +0.7% | +$2.99K |
|
364
Labcorp
LH
$26.1B
| $397K | 0.02% |
1,973
| – | – |
|
365
DexCom
DXCM
$34.1B
| $396K | 0.02% |
5,312
+420
| +9% | +$38.3K |
|
366
Schwab U.S Small- Cap ETF
SCHA
$23.5B
| $396K | 0.02% |
20,294
+18
| +0.1% | +$385 |
|
367
Unilever
UL
$134B
| $395K | 0.02% |
7,668
+223
| +3% | +$11.4K |
|
368
Archer Daniels Midland
ADM
$38.8B
| $390K | 0.02% |
5,028
+2
| +0% | +$175 |
|
|
MSB
369
Mesabi Trust
MSB
$302M
| $388K | 0.02% |
15,850
| – | – |
|
370
S&P Global
SPGI
$122B
| $388K | 0.02% |
1,152
+5
| +0.4% | +$1.78K |
|
|
MZTI
371
The Marzetti Company
MZTI
$3.23B
| $386K | 0.02% |
2,994
| – | – |
|
372
iShares National Muni Bond ETF
MUB
$45.9B
| $383K | 0.02% |
3,598
-2,636
| -42% | -$281K |
|
373
APA Corp
APA
$13.9B
| $373K | 0.02% |
10,700
-1,500
| -12% | -$63.8K |
|
374
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
| $369K | 0.02% |
15,428
+1,510
| +11% | +$36.5K |
|
375
MetLife
MET
$61.7B
| $368K | 0.02% |
5,866
| – | – |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
O
Carnegie Investment Counsel's Q2 2022 Portfolio in Review
As of Q2 2022, Carnegie Investment Counsel held 511 positions worth $2.21B, down 19% from $2.74B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Carnegie Investment Counsel's Q2 2022 filing shows 25 new, 176 increased, 220 reduced and 40 closed positions. Its largest new stake was Progyny: 306,283 shares worth $8.9M. The largest sale was Invesco BulletShares 2022 Corporate Bond ETF, an estimated $11.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.
- Carnegie Investment Counsel's largest Q2 2022 buy was Progyny: 306,283 shares worth $8.9M.
- Carnegie Investment Counsel added most to Berkshire Hathaway Class B in Q2 2022, an estimated $4.8M increase.
- Carnegie Investment Counsel's biggest Q2 2022 reduction was Invesco BulletShares 2022 Corporate Bond ETF, cutting an estimated $11.2M.
- Carnegie Investment Counsel fully exited QuantumScape Corp in Q2 2022, selling an estimated $5.61M.
- Carnegie Investment Counsel's ten largest holdings make up 22% of its $2.21B portfolio in Q2 2022.
- Carnegie Investment Counsel opened 25 new positions and closed 40 in Q2 2022.
- Carnegie Investment Counsel's portfolio value fell 19% quarter-over-quarter to $2.21B.
Based on Carnegie Investment Counsel's 13F filing for Q2 2022, filed 13 Jul 2022.